GHRL and neoplasm: Overall, these results observed in response to In1-ghrelin peptide(s) treatment (i.e. an increase in proliferation rate and a decrease apoptotic rate) suggest that In1-ghrelin variant might represent a regulatory mechanism to control tumor growth in GH-oma cells.